Boyalife Pharma

Boyalife Pharma is a prominent biotechnology company under the Boyalife Group, focusing on the development and commercialization of regenerative medicine and cell-based therapies. The company operates extensive stem cell banking facilities and has established a robust platform for automated cell processing and clinical-grade manufacturing. Boyalife's research and development efforts are primarily centered on mesenchymal stem cell (MSC) applications for treating degenerative and autoimmune diseases. Through its subsidiary ThermoGenesis Holdings, the company provides advanced solutions for automated cell processing to the global market. Boyalife gained significant international visibility for its large-scale animal cloning projects and its strategic expansion into precision medicine. The company continues to advance several clinical programs targeting indications such as osteoarthritis and cardiovascular disorders.